全球肠外营养市场规模、份额和成长分析：按营养类型、按阶段类型、按症状、按销售管道、按地区 - 产业预测（2024-2031）

2022年全球肠外营养市场规模将为67亿美元，从2023年的71亿美元成长到2031年的114亿美元，预计在预测期内（2024-2031年）复合年增长率为6.0%。

由于面临营养不良风险的老年人口的扩大，以及癌症和胃肠道疾病等慢性疾病的增加，预计全球肠外营养市场将继续成长。肠外营养製剂的最新进展，包括提供可客製化营养组合的多室袋，改善了患者护理并简化了给药。然而，该市场面临一些挑战，例如与长期治疗相关的感染风险、产品和设备的高成本以及限制可及性的监管障碍，特别是在新兴地区。严格的感染控制措施、专业化生产和标准化指南的需求使市场动态变得复杂。总体而言，创新产品开发和监管协调对于应对这些挑战和支持市场扩张至关重要。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析和影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 价值链分析
• 专利分析
• PESTEL分析
• 总体经济指标
• 市场吸引力指数

肠外营养市场规模：依营养类型，复合年增长率（2024-2031）

• 市场概况
• 碳水化合物
• 肠外脂肪乳剂
• 单剂量氨基酸溶液
• 微量元素
• 维生素和矿物质

肠外营养市场规模：依阶段类型，复合年增长率（2024-2031）

• 市场概况
• 成人
• 儿科的

肠外营养市场规模：依症状，复合年增长率（2024-2031）

• 市场概况
• 阿兹海默症
• 营养不良
• 癌症治疗
• 糖尿病
• 慢性肾臟病
• 罕见疾病
• 吞嚥困难
• 疼痛管理
• 吸收不良/胃肠道疾病/腹泻
• 其他的

肠外营养市场规模：依销售管道划分，复合年增长率（2024-2031）

• 市场概况
• 在线的
• 零售
• 机构

肠外营养市场规模，复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• B. Braun Melsungen AG
• Fresenius Kabi AG
• Sichuan Kelun Industrial Group Co Ltd
• Pfizer Inc.
• Baxter International Inc.
• Grifols SA
• Otsuka Holdings Co. Ltd（Otsuka Pharmaceutical Co., Ltd.）
• Nirma Group（Aculife Healthcare Pvt. Ltd.）
• Abbott Laboratories
• Medtronic
• Beximco Pharmaceuticals Ltd.
• Sichuan Luye Pharmaceutical Co., Ltd.
• ICU Medical, Inc.
• JW Pharmaceutical Corporation
• Servona GmbH
• Anhui Medipharm Co., Ltd.
• Nipro Corporation
• Biosyn Arzneimittel
• Terumo Corporation
• Lonza Group

结论和建议

Global Parenteral Nutrition Market size was valued at USD 6.7 billion in 2022 and is poised to grow from USD 7.1 billion in 2023 to USD 11.4 billion by 2031, growing at a CAGR of 6.0% during the forecast period (2024-2031).

The global parenteral nutrition market is poised for continued growth, driven by rising chronic diseases such as cancer and gastrointestinal disorders, alongside an increasing geriatric population at risk of malnutrition. Recent advancements in parenteral nutrition formulations, including multi-chamber bags that offer customizable nutrient combinations, have enhanced patient care and ease of administration. However, the market faces challenges like infection risks associated with long-term therapy, high costs of products and equipment, and regulatory hurdles that can limit accessibility, especially in developing regions. The need for stringent infection control measures, specialized manufacturing, and standardized guidelines complicates market dynamics. Overall, innovative product development and harmonized regulations will be crucial for addressing these challenges and supporting market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Parenteral Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Parenteral Nutrition Market Segmental Analysis

Global Parenteral Nutrition Market is segmented by Nutrition Type, Stage Type, Indication, Sales Channel and region. Based on Nutrition Type, the market is segmented into Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals. Based on Stage Type, the market is segmented into Adult, Pediatrics. Based on Indication, the market is segmented into Alzheimer's, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Disease, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others. Based on Sales Channel, the market is segmented into Online, Retail, and Institutional. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Parenteral Nutrition Market

The global market for parenteral nutrition is significantly driven by technological advancements in product formulations and delivery systems. Innovations in nutrient combinations and formulation techniques have markedly improved the safety and effectiveness of parenteral nutrition therapies. These enhancements not only streamline the administration process for healthcare providers but also increase comfort and tolerance for patients undergoing treatment. As a result, the upgraded products and methods are expanding the reach and application of parenteral nutrition, reinforcing its vital role in supporting patients who cannot receive adequate nutrition through traditional means. Such developments are crucial in meeting the growing demand for specialized nutritional care on a global scale.

Restraints in the Global Parenteral Nutrition Market

The global parenteral nutrition market faces significant restraints, primarily due to regulatory constraints and the absence of standardized protocols. Divergent regulations and inconsistent guidelines for parenteral nutrition therapy in various regions create hurdles for both manufacturers and healthcare professionals. This lack of uniformity can lead to complications in ensuring the safe and effective delivery of parenteral nutrition. To overcome these challenges, it is crucial to establish harmonized regulatory frameworks and develop evidence-based guidelines that can foster consistency and enhance patient care across different geographic locations. Addressing these issues is vital for the growth and stability of the market.

Market Trends of the Global Parenteral Nutrition Market

The Global Parenteral Nutrition market is witnessing a significant trend toward the integration of digital health technologies, including mobile applications, connected devices, and telehealth solutions. This shift facilitates remote monitoring and real-time data collection, which enhances communication between patients, caregivers, and healthcare providers. As a result, healthcare professionals can better manage parenteral nutrition therapy, leading to improved treatment outcomes and patient satisfaction. The increasing focus on personalized medicine and the rising demand for remote healthcare solutions are driving this trend, indicating a robust growth trajectory for the market as technology plays an essential role in optimizing nutritional support.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Value Chain Analysis
• Patent Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index

Global Parenteral Nutrition Market Size by Nutrition Type & CAGR (2024-2031)

• Market Overview
• Carbohydrates
• Parenteral Lipid Emulsion
• Single Dose Amino Acid Solution
• Trace Elements
• Vitamins & Minerals

Global Parenteral Nutrition Market Size by Stage Type & CAGR (2024-2031)

• Market Overview
• Adult
• Pediatrics

Global Parenteral Nutrition Market Size by Indication & CAGR (2024-2031)

• Market Overview
• Alzheimer's
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Malabsorption/GI Disorder/Diarrhea
• Others

Global Parenteral Nutrition Market Size by Sales Channel & CAGR (2024-2031)

• Market Overview
• Online
• Retail
• Institutional

Global Parenteral Nutrition Market Size & CAGR (2024-2031)

• North America (Nutrition Type, Stage Type, Indication, Sales Channel)
  • US
  • Canada
• Europe (Nutrition Type, Stage Type, Indication, Sales Channel)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Nutrition Type, Stage Type, Indication, Sales Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Nutrition Type, Stage Type, Indication, Sales Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Nutrition Type, Stage Type, Indication, Sales Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sichuan Kelun Industrial Group Co Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Holdings Co. Ltd (Otsuka Pharmaceutical Co., Ltd.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nirma Group (Aculife Healthcare Pvt. Ltd.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beximco Pharmaceuticals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sichuan Luye Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JW Pharmaceutical Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Servona GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anhui Medipharm Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosyn Arzneimittel
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation